Search tips
Search criteria 


Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
Infect Immun. 1997 August; 65(8): 3065–3073.
PMCID: PMC175432

Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response.


Whether there is a pathogenic or protective outcome to chlamydial infection may be defined by the host response. We infected C57BL/6 (C57) and C3H/HeN (C3H) mice with the human biovar of Chlamydia trachomatis, serovar E, and, in select experiments, with the mouse pneumonitis agent of C. trachomatis (MoPn). We compared the courses of infection, histopathology, and host responses that resulted from these infections. The duration of infection with either chlamydial biovar was significantly increased in the C3H strain of mice. The intensity of infection was examined in mice infected with serovar E, and it was significantly increased in the C3H strain. Histopathology revealed the incidence of severe hydrosalpinx to be significantly greater in C3H mice than in C57 mice. In contrast, severe distention of the uterine horns was observed in all infected C57 mice compared to none of the C3H mice infected with serovar E and only 25% of those infected with MoPn. Acute inflammation was significantly increased in the uterine horns of C57 mice compared to that of C3H mice. Examination of antigen-specific responses revealed qualitatively similar responses in the two strains. Determination of gamma interferon- versus interleukin 4- producing cells revealed the predominance of a Th1 response in both strains. Serum enzyme-linked immunosorbent assays for immunoglobulin G1 (IgG1) and IgG2a revealed a predominance of IgG2a antibody in both strains, although the levels of antibody were significantly greater in C3H mice. Lymphocyte proliferation studies revealed increased proliferation in the iliac nodes of both strains at 1 to 3 weeks after infection. Because of the early eradication of infection observed in the C57 strain, we explored the relative production of tumor necrosis factor alpha (TNF-alpha) in the two strains. TNF-alpha levels were significantly increased in the genital tract secretions of C57 mice compared to that of C3H mice during the first week of infection. Increased TNF-alpha may be beneficial to the host by leading to earlier eradication of infection, thereby preventing infection of the oviduct and thus the major disease sequelae associated with chlamydial infection of the genital tract.

Full Text

The Full Text of this article is available as a PDF (667K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Cain TK, Rank RG. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun. 1995 May;63(5):1784–1789. [PMC free article] [PubMed]
  • Caldwell HD, Kromhout J, Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun. 1981 Mar;31(3):1161–1176. [PMC free article] [PubMed]
  • Cates W, Jr, Wasserheit JN. Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol. 1991 Jun;164(6 Pt 2):1771–1781. [PubMed]
  • Darville T, Laffoon KK, Kishen LR, Rank RG. Tumor necrosis factor alpha activity in genital tract secretions of guinea pigs infected with chlamydiae. Infect Immun. 1995 Dec;63(12):4675–4681. [PMC free article] [PubMed]
  • de la Maza LM, Pal S, Khamesipour A, Peterson EM. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun. 1994 May;62(5):2094–2097. [PMC free article] [PubMed]
  • Ito JI, Jr, Lyons JM, Airo-Brown LP. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection. Infect Immun. 1990 Jun;58(6):2021–2023. [PMC free article] [PubMed]
  • Jacob CO, Lee SK, Strassmann G. Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3'-untranslated region in the genetic predisposition to lupus-like autoimmune disease. J Immunol. 1996 Apr 15;156(8):3043–3050. [PubMed]
  • Katz BP, Batteiger BE, Jones RB. Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis. Sex Transm Dis. 1987 Jul-Sep;14(3):160–164. [PubMed]
  • Kelly KA, Robinson EA, Rank RG. Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection. Infect Immun. 1996 Dec;64(12):4976–4983. [PMC free article] [PubMed]
  • Magee DM, Smith JG, Bleicker CA, Carter CJ, Bonewald LF, Schachter J, Williams DM. Chlamydia trachomatis pneumonia induces in vivo production of interleukin-1 and -6. Infect Immun. 1992 Mar;60(3):1217–1220. [PMC free article] [PubMed]
  • Magee DM, Williams DM, Wing EJ, Bleicker CA, Schachter J. Production of colony-stimulating factors during pneumonia caused by Chlamydia trachomatis. Infect Immun. 1991 Jul;59(7):2370–2375. [PMC free article] [PubMed]
  • McCormack WM. Pelvic inflammatory disease. N Engl J Med. 1994 Jan 13;330(2):115–119. [PubMed]
  • Møller BR, Weström L, Ahrons S, Ripa KT, Svensson L, von Mecklenburg C, Henrikson H, Mårdh PA. Chlamydia trachomatis infection of the Fallopian tubes. Histological findings in two patients. Br J Vener Dis. 1979 Dec;55(6):422–428. [PMC free article] [PubMed]
  • Rasmussen SJ, Eckmann L, Quayle AJ, Shen L, Zhang YX, Anderson DJ, Fierer J, Stephens RS, Kagnoff MF. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest. 1997 Jan 1;99(1):77–87. [PMC free article] [PubMed]
  • Tuffrey M, Alexander F, Conlan W, Woods C, Ward M. Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlamydia trachomatis by prior immunization with recombinant serovar L1 major outer-membrane protein. J Gen Microbiol. 1992 Aug;138(Pt 8):1707–1715. [PubMed]
  • Tuffrey M, Falder P, Gale J, Taylor-Robinson D. Salpingitis in mice induced by human strains of Chlamydia trachomatis. Br J Exp Pathol. 1986 Aug;67(4):605–616. [PubMed]
  • Washington AE, Johnson RE, Sanders LL., Jr Chlamydia trachomatis infections in the United States. What are they costing us? JAMA. 1987 Apr 17;257(15):2070–2072. [PubMed]
  • Williams DM, Magee DM, Bonewald LF, Smith JG, Bleicker CA, Byrne GI, Schachter J. A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect Immun. 1990 Jun;58(6):1572–1576. [PMC free article] [PubMed]
  • Wood PR, Spanidis V, Frangos K, Cheers C. The in vitro bactericidal activity of peritoneal and spleen cells from Listeria-resistant and -susceptible mouse strains. Cell Immunol. 1986 Apr 15;99(1):160–169. [PubMed]
  • Yang X, HayGlass KT, Brunham RC. Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol. 1996 Jun 1;156(11):4338–4344. [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)